Ascendis Pharma A/S Ordinary Share Earnings Dividend

Ascendis Pharma A/S Ordinary Share’s revenue jumped 148.29% since last year same period to $250.66Mn in the Q1 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated 2.23% jump in its revenue since last 3-months.

Ascendis Pharma A/S Ordinary Share’s net profit jumped 776.02% since last year same period to $639.69Mn in the Q1 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated 2024.03% jump in its net profits since last 3-months.

Ascendis Pharma A/S Ordinary Share’s net profit margin jumped 372.27% since last year same period to 255.21% in the Q1 2026. On a quarterly growth basis, Ascendis Pharma A/S Ordinary Share has generated 1981.99% jump in its net profit margins since last 3-months.

Ascendis Pharma A/S Ordinary Share’s price-to-earnings ratio after this Q1 2026 earnings stands at 29.19.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) estimates for the current quarter stand at 0.78 - a 81.4% jump from last quarter’s estimates.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) estimates for the current year stand at 0.78.

Ascendis Pharma A/S Ordinary Share’s earning per share (EPS) jumped 0% since last year same period to -0.93 in the Q2 2026. This indicates that the Ascendis Pharma A/S Ordinary Share has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.